217 related articles for article (PubMed ID: 27914516)
1. Leukotriene B4 induces EMT and vimentin expression in PANC-1 pancreatic cancer cells: Involvement of BLT2 via ERK2 activation.
Kim YR; Park MK; Kang GJ; Kim HJ; Kim EJ; Byun HJ; Lee MY; Lee CH
Prostaglandins Leukot Essent Fatty Acids; 2016 Dec; 115():67-76. PubMed ID: 27914516
[TBL] [Abstract][Full Text] [Related]
2. Novel involvement of leukotriene B₄ receptor 2 through ERK activation by PP2A down-regulation in leukotriene B₄-induced keratin phosphorylation and reorganization of pancreatic cancer cells.
Park MK; Park Y; Shim J; Lee HJ; Kim S; Lee CH
Biochim Biophys Acta; 2012 Dec; 1823(12):2120-9. PubMed ID: 23017243
[TBL] [Abstract][Full Text] [Related]
3. Leukotriene B4 receptor antagonist LY293111 inhibits proliferation and induces apoptosis in human pancreatic cancer cells.
Tong WG; Ding XZ; Hennig R; Witt RC; Standop J; Pour PM; Adrian TE
Clin Cancer Res; 2002 Oct; 8(10):3232-42. PubMed ID: 12374694
[TBL] [Abstract][Full Text] [Related]
4. Leukotriene B4 enhances the activity of nuclear factor-kappaB pathway through BLT1 and BLT2 receptors in atherosclerosis.
Sánchez-Galán E; Gómez-Hernández A; Vidal C; Martín-Ventura JL; Blanco-Colio LM; Muñoz-García B; Ortega L; Egido J; Tuñón J
Cardiovasc Res; 2009 Jan; 81(1):216-25. PubMed ID: 18852255
[TBL] [Abstract][Full Text] [Related]
5. Leukotriene B4 receptors BLT1 and BLT2: expression and function in human and murine mast cells.
Lundeen KA; Sun B; Karlsson L; Fourie AM
J Immunol; 2006 Sep; 177(5):3439-47. PubMed ID: 16920986
[TBL] [Abstract][Full Text] [Related]
6. Differential Contribution of BLT1 and BLT2 to Leukotriene B4-Induced Human NK Cell Cytotoxicity and Migration.
Wang M; Mostafa El-Maghraby N; Turcotte S; Rola-Pleszczynski M; Stankova J
Mediators Inflamm; 2015; 2015():389849. PubMed ID: 26696753
[TBL] [Abstract][Full Text] [Related]
7. Ras promotes transforming growth factor-β (TGF-β)-induced epithelial-mesenchymal transition via a leukotriene B4 receptor-2-linked cascade in mammary epithelial cells.
Kim H; Choi JA; Kim JH
J Biol Chem; 2014 Aug; 289(32):22151-60. PubMed ID: 24990945
[TBL] [Abstract][Full Text] [Related]
8. Leukotriene B4 stimulates human monocyte-derived dendritic cell chemotaxis.
Shin EH; Lee HY; Bae YS
Biochem Biophys Res Commun; 2006 Sep; 348(2):606-11. PubMed ID: 16889750
[TBL] [Abstract][Full Text] [Related]
9. Suppression of the Epidermal Growth Factor-like Domain 7 and Inhibition of Migration and Epithelial-Mesenchymal Transition in Human Pancreatic Cancer PANC-1 Cells.
Wang YL; Dong FL; Yang J; Li Z; Zhi QM; Zhao X; Yang Y; Li DC; Shen XC; Zhou J
Asian Pac J Cancer Prev; 2015; 16(9):4065-9. PubMed ID: 25987088
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a mouse second leukotriene B4 receptor, mBLT2: BLT2-dependent ERK activation and cell migration of primary mouse keratinocytes.
Iizuka Y; Yokomizo T; Terawaki K; Komine M; Tamaki K; Shimizu T
J Biol Chem; 2005 Jul; 280(26):24816-23. PubMed ID: 15866883
[TBL] [Abstract][Full Text] [Related]
11. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells.
Wang F; Li H; Yan XG; Zhou ZW; Yi ZG; He ZX; Pan ST; Yang YX; Wang ZZ; Zhang X; Yang T; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():575-601. PubMed ID: 25632225
[TBL] [Abstract][Full Text] [Related]
12. BLT2 is expressed in PanINs, IPMNs, pancreatic cancer and stimulates tumour cell proliferation.
Hennig R; Osman T; Esposito I; Giese N; Rao SM; Ding XZ; Tong WG; Büchler MW; Yokomizo T; Friess H; Adrian TE
Br J Cancer; 2008 Oct; 99(7):1064-73. PubMed ID: 18781173
[TBL] [Abstract][Full Text] [Related]
13. Identification, signaling, and functions of LTB
Saeki K; Yokomizo T
Semin Immunol; 2017 Oct; 33():30-36. PubMed ID: 29042026
[TBL] [Abstract][Full Text] [Related]
14. [
Zhang RH; Huang JP; Li JW; Li YQ; Cui XY; Xiong YN; Liu YK; Zhang GL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 May; 54(3):558-564. PubMed ID: 37248584
[TBL] [Abstract][Full Text] [Related]
15. Mediatory role of BLT2 in the proliferation of KRAS mutant colorectal cancer cells.
Park J; Jang JH; Kim JH
Biochim Biophys Acta Mol Cell Res; 2019 Mar; 1866(3):329-336. PubMed ID: 30553812
[TBL] [Abstract][Full Text] [Related]
16. Curcumin reverses the epithelial-mesenchymal transition of pancreatic cancer cells by inhibiting the Hedgehog signaling pathway.
Sun XD; Liu XE; Huang DS
Oncol Rep; 2013 Jun; 29(6):2401-7. PubMed ID: 23563640
[TBL] [Abstract][Full Text] [Related]
17. Macrophage LTB
Zhang Y; Olson RM; Brown CR
J Lipid Res; 2017 Mar; 58(3):494-503. PubMed ID: 28053185
[TBL] [Abstract][Full Text] [Related]
18. Suppression of the epidermal growth factor receptor inhibits epithelial-mesenchymal transition in human pancreatic cancer PANC-1 cells.
Chang ZG; Wei JM; Qin CF; Hao K; Tian XD; Xie K; Xie XH; Yang YM
Dig Dis Sci; 2012 May; 57(5):1181-9. PubMed ID: 22271412
[TBL] [Abstract][Full Text] [Related]
19. Leukotriene B4 Inhibits L-Type Calcium Channels via p38 Signaling Pathway in Vascular Smooth Muscle Cells.
Liu X; Yang T; Miao L; Mei YA; Hu C
Cell Physiol Biochem; 2015; 37(5):1903-13. PubMed ID: 26584289
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of GP73 promotes cell invasion, migration and metastasis by inducing epithelial-mesenchymal transition in pancreatic cancer.
Song YX; Xu ZC; Li HL; Yang PL; Du JK; Xu J
Pancreatology; 2018 Oct; 18(7):812-821. PubMed ID: 30217697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
